My Companies
Notification
Account
Log Out
Login
Piramal Pharma's Sellersville, USA manufacturing facility received an Establishment Inspection Report from the US FDA, successfully closing the inspection without adverse findings.
Piramal Pharma Receives Form 483 With Seven Observations For Morpeth Facility
Piramal Pharma Recreates Pledge Over 98.4 Million Shares
Piramal Pharma Reports Release Of 7.39% Share Pledge
Piramal Pharma Exercises Call Option For 41% Yapan Stake